GO2 Foundation for Lung Cancer has created a multi-institutional study to determine how to improve the participation of Black communities in lung cancer clinical trials.
An NCI study demonstrated that people who have had evidence of a prior infection with SARS-CoV-2, the virus that causes COVID-19, appear to be well protected against being reinfected with the virus, at least for a few months.
A study conducted in spring of 2020 demonstrated that one-third of U.S. cancer survivors are worried about treatment and cancer care disruptions during the COVID-19 pandemic.
The National Comprehensive Cancer Network, American Cancer Society Cancer Action Network, and the National Minority Quality Forum have developed recommendations on how to lessen racial disparities in cancer care.
A study from researchers at University of North Carolina at Chapel Hill has found that smokers who saw messages about tobacco chemicals with associated health risks, together with graphic health images and information promoting quitting, expressed greater desire to quit smoking.
The National Comprehensive Cancer Network published its first-ever treatment guidelines for children with a solid tumor cancer type in the United States.
In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer.
A test that monitors blood levels of DNA fragments released by dying tumor cells may serve as an accurate early indicator of treatment success in late stages of melanoma.
Researchers examined body mass index data for people with HER2-positive early breast cancer and found a 5% weight loss in patients over two years was associated with worse outcomes.
Black women experience longer breast cancer treatment times and may have less access to essential radiation technology, according to a study published in Cancer.